Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight
Дата публикации: 27-08-2026 19:35:26

The U.S. Food and Drug Administration did not unlawfully remove blockbuster GLP-1 medications made by Eli Lilly & Co. and Novo Nordisk from the national drug shortage list, the Fifth Circuit ruled Thursday, handing a loss to compounding pharmacies that produce copycat doses of the drugs.

Основное содержимое страницы с новостью.

5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight

By Lauren Berg ( August 27, 2026, 7:35 PM EDT) -- The U.S. Food and Drug Administration did not unlawfully remove blockbuster GLP-1 medications made by Eli Lilly & Co. and Novo Nordisk from the national drug shortage list, the Fifth Circuit ruled Thursday, handing a loss to compounding pharmacies that produce copycat doses of the drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Ex-Eli Lilly Rep Can't File Whistleblower Claims In NJ011.6528-08-2026
2Eli Lilly targets alleged black market sales of its experimental GLP-1 drug09.212-08-2026
3Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads0721-07-2026
4Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising09.1822-07-2026
5Meta Can't Arbitrate Deceptive Ads Suit, 7th Circ. Rules08.2627-08-2026
6The Biggest Trade Secret Rulings Of 2026: A Midyear Report0717-07-2026
7Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know5701-07-2026
8GLP-1 use hits record high as Medicare opens access to weight-loss drugs0709-07-2026
9Fed. Circ. Doubts $9M Atty Fees Without Dismissal Attempt-2609-07-2026

Классификация: Международные. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.62. Источник: www.law360.com.